Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Lantern Pharma Inc. has filed 255 SEC EDGAR filings since 14 Jan 2019

SEC filing history

Showing 201-225 of 255 matching filings.

Per page
25
Current page
9
8-K File 001-39318

CURRENT REPORT

Filing date
16 Jul 2020
Reporting date
10 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91536

SC 13D

Filing date
23 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91536

SCHEDULE 13D

Filing date
23 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91536

SCHEDULE 13D

Filing date
19 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
17 Jun 2020
Reporting date
11 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
16 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
15 Jun 2020
Reporting date
11 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-237714

PROSPECTUS

Filing date
12 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-239112

REGISTRATION STATEMENT

Filing date
12 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-237714

EFFECT filing

Filing date
10 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .